搜尋
諾和諾德
NVO添加自選
48.550USD
+0.370+0.77%
收盤 07-23 16:00（美東）報價延遲15分鐘
163.30B總市值
11.36本益比TTM
關於 諾和諾德 公司
諾和諾德是一家專注糖尿病護理的全球醫療健康公司，同時涉足藥物的發現、研發、生產與行銷。公司透過「糖尿病與肥胖護理」及「生物製藥」兩大業務運作。前者產品組合含胰島素、GLP-1 受體激動劑（Ozempic、Wegovy、Rybelsus 等） 、胰高血糖素等蛋白質類療法、蛋白質投遞系統與注射針頭，以及口服降糖藥；後者聚焦血友病護理、生長激素補充及激素替代治療。另有 Saxenda 專門針對臨床肥胖症。主要品牌包含 NovoLog/NovoRapid、NovoLog Mix/NovoMix、Prandin/NovoNorm、NovoSeven、Norditropin、Vagifem 等。公司藥品銷往逾一百八十個國家，全球商業體系由北美與國際運營兩大區域組成，透過臨床研究、製造網絡與市場渠道將療法帶給患者。
諾和諾德簡介
公司代碼NVO
公司名稱Novo Nordisk A/S
上市日期May 17, 1974
CEODoustdar (Maziar Mike)
員工數量76302
證券類型Depository Receipt
年結日May 17
公司地址Novo Alle 1
城市BAGSVAERD
上市交易所NASDAQ OMX NASDAQ Basic NYSE
國家Denmark
郵編2880
電話4544448888
網址https://www.novonordisk.com/
公司代碼NVO
上市日期May 17, 1974
CEODoustdar (Maziar Mike)
諾和諾德公司高管
名稱
名稱/職務
職務
持股
持股變動
Mr. Lars Rebien Soerensen
Mr. Lars Rebien Soerensen
Chairman of the Board
Chairman of the Board
--
--
Ms. Liselotte Hyveled
Ms. Liselotte Hyveled
Director, Employee Representative
Director, Employee Representative
--
--
Mr. Maziar Mike Doustdar
Mr. Maziar Mike Doustdar
President, Chief Executive Officer
President, Chief Executive Officer
--
--
Mr. Henrik Ehlers Wulff
Mr. Henrik Ehlers Wulff
Executive Vice President - Product Supply
Executive Vice President - Product Supply
--
--
Mr. Kasim Kutay
Mr. Kasim Kutay
Director
Director
--
--
Ms. Mette Boejer Jensen
Ms. Mette Boejer Jensen
Director, Employee Representative
Director, Employee Representative
--
--
Mr. Thomas Rantzau
Mr. Thomas Rantzau
Director, Employee Representative
Director, Employee Representative
--
--
Mr. Karsten Munk Knudsen
Mr. Karsten Munk Knudsen
Chief Financial Officer, Executive Vice President
Chief Financial Officer, Executive Vice President
--
--
Mr. Ludovic Helfgott
Mr. Ludovic Helfgott
Executive Vice President - Product & Portfolio Strategy
Executive Vice President - Product & Portfolio Strategy
--
--
Dr. Martin Holst Lange
Dr. Martin Holst Lange
Executive Vice President, Chief Scientific Officer, Research & Development
Executive Vice President, Chief Scientific Officer, Research & Development
--
--
查看更多
名稱
名稱/職務
職務
持股
持股變動
Mr. Lars Rebien Soerensen
Mr. Lars Rebien Soerensen
Chairman of the Board
Chairman of the Board
--
--
Ms. Liselotte Hyveled
Ms. Liselotte Hyveled
Director, Employee Representative
Director, Employee Representative
--
--
Mr. Maziar Mike Doustdar
Mr. Maziar Mike Doustdar
President, Chief Executive Officer
President, Chief Executive Officer
--
--
Mr. Henrik Ehlers Wulff
Mr. Henrik Ehlers Wulff
Executive Vice President - Product Supply
Executive Vice President - Product Supply
--
--
Mr. Kasim Kutay
Mr. Kasim Kutay
Director
Director
--
--
Ms. Mette Boejer Jensen
Ms. Mette Boejer Jensen
Director, Employee Representative
Director, Employee Representative
--
--
常見問題
諾和諾德的前五大股東是誰？
諾和諾德的前五大股東如下：Mr. Lars Rebien Soerensen
有多少機構持有諾和諾德(NVO)的股份？
截至2026Q1，共有2975家機構持有諾和諾德的股份，合計持有的股份價值約為332.82M，占公司總股份的9.89% 。與2025Q4相比，機構持股有所增加，增幅為-2714627.00。
哪個業務部門對諾和諾德的收入貢獻最大？
在2026Q1，Total GLP-1業務部門對諾和諾德的收入貢獻最大，創收23.00B，占總收入的49.25% 。